Evidence map›Paper›PMID 28504542›Full record

Trial reportJournal of consulting and clinical psychology2017

Do changes in trauma-related beliefs predict PTSD symptom improvement in prolonged exposure and sertraline?

Andrew A Cooper, Lori A Zoellner, Peter Roy-Byrne, Matig R Mavissakalian, Norah C Feeny

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of consulting and clinical psychology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Intranasal hydrogel of armodafinil hydroxypropyl-β-cyclodextrin inclusion complex for the treatment of post-traumatic stress disorder.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Andrew A CooperDepartment of Psychological Sciences, Case Western Reserve University.
Lori A ZoellnerDepartment of Psychology, University of Washington.
Peter Roy-ByrneDepartment of Psychiatry, University of Washington.
Matig R MavissakalianDepartment of Psychiatry, Case Western Reserve University.
Norah C FeenyDepartment of Psychological Sciences, Case Western Reserve University.
Case Western Reserve University · USUniversity of Washington · US

Funding

Effectiveness of PTSD Treatment: Prolonged Exposure Therapy vs. ZoloftR01MH066347 · NIMH · UNIVERSITY OF WASHINGTON · PI ZOELLNER, LORI A · 2004 to 2014
$4.3M
Effectiveness of PTSD Treatment: PE vs ZoloftR01MH066348 · NIMH · CASE WESTERN RESERVE UNIVERSITY · PI FEENY, NORAH C · 2004 to 2014
$4.3M
National Institute of Mental HealthNIMH NIH HHS R01 MH066347NIMH NIH HHS R01 MH066348William T. Dahms, Clinical Research Unit
6 · The paper itself

Abstract

objectiveNegative trauma-related belief change has been found to predict subsequent improvement in symptoms of posttraumatic stress disorder (PTSD) in prolonged exposure (PE) and other therapies, consistent with several psychological theories of treatment change (e.g., Foa & Kozak, 1986). However, belief change has not been examined in selective serotonin reuptake inhibitors such as sertraline. We examined processes associated with symptom improvement in 2 treatments for PTSD, hypothesizing that belief change would robustly predict PTSD improvement in patients treated with PE but not those treated with sertraline, reflecting moderation by treatment.

methodPatients with chronic PTSD (N = 134; 78% women, 71.6% Caucasian, M = 38.1 years, SD = 11.8) received 10 weeks of PE or sertraline in a randomized, controlled trial. Patients reported PTSD and depression symptoms, and trauma-related beliefs (Post-Traumatic Cognitions Inventory; Foa, Ehlers, Clark, D Tolin, & Orsillo, 1999) at pretreatment, every treatment session, and posttreatment.

resultsUsing time-lagged mixed regression models, change in trauma-related beliefs predicted subsequent PTSD symptom improvement, an effect moderated by treatment and particularly strong in PE (d = 0.93) compared with sertraline (d = 0.35). Belief change also predicted depressive symptom improvement but more modestly and bidirectionally, with no difference by treatment modality.

conclusionsTrauma-related belief change precedes PTSD improvement more robustly in PE than in sertraline and with greater specificity compared with depressive symptoms. These findings highlight potentially divergent processes contributing to symptom change in these PTSD treatments, with belief change as a key mechanism of PE. (PsycINFO Database Record

Indexed as

Outcome Assessment, Health CareAdultDepressionFemaleHumansImplosive TherapyMaleMiddle AgedSelective Serotonin Reuptake InhibitorsSertralineStress Disorders, Post-TraumaticThinkingTreatment OutcomeSelective Serotonin Reuptake InhibitorsSertraline

Identifiers

PMID28504542
PMCPMC5578884
OpenAlexW2614970949

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.